Clinical Trials Browser

Has results × pazopanib × Thoracic × Clear all

NCT02193152 2020-07-14

Pazopanib in Molecularly Selected Patients With Advanced NSCLC

Phase 2 Terminated

16 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT01253369 2019-04-23

Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Completed

33 enrolled 8 charts

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01012362 2017-12-28

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Phase 1 Terminated

31 enrolled 12 charts

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT01262820 2017-03-07

LCCC0921

Phase 2 Completed

15 enrolled 10 charts

Lung Neoplasms

NCT01027598 2016-01-29

Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

Phase 2 Completed

202 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00549328 2014-11-19

Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

Phase 2 Terminated

14 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung

NCT01049776 2014-09-19

GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line

Phase 2 Terminated

32 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT00871403 2013-06-20

Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer

Phase 2 Completed

107 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00367679 2012-06-12

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

Phase 2 Completed

35 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung